Elevated CSF Corticotropin-releasing Factor Concentrations in Posttraumatic Stress Disorder

Overview

Journal Am J Psychiatry

Specialty Psychiatry

Date 1997 May 1

PMID 9137116

Citations 204

Authors

J D Bremner

J Licinio

A Darnell

J H Krystal

M J Owens

S M Southwick

C B Nemeroff

D S Charney

Affiliations

Soon will be listed here.

Abstract

Objective: Corticotropin-releasing factor (CRF) and somatostatin both play important roles in mediating responses to acute and chronic stress. The purpose of this study was to measure CSF concentrations of CRF and somatostatin in patients with chronic combat-related post-traumatic stress disorder (PTSD) and comparison subjects.

Method: Lumbar punctures for collection of CSF were performed in Vietnam combat veterans with PTSD (N = 11) and comparison subjects (N = 17). CSF concentrations of CRF and somatostatin were compared between the two groups.

Results: CSF concentrations of CRF were higher in the PTSD patients than in the comparison subjects (mean = 29.0 pg/ml, SD = 7.8, versus mean = 21.9 pg/ml, SD = 6.0). This group difference remained significant after covariance for age. CSF somatostatin concentrations in PTSD patients were higher than those of the comparison subjects (mean = 19.9 pg/ml, SD = 5.4, versus mean = 13.7 pg/ml, SD = 8.0). However, covarying for age reduced the level of significance.

Conclusions: Higher CSF CRF concentrations in patients with PTSD may reflect alterations in stress-related neurotransmitter systems. The higher CSF CRF concentrations may play a role in disturbances of arousal in patients with PTSD.

Citing Articles

Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders.

Fernandes Gomes B, Kumar A, Ashton N, Hall S, Stomrud E, Smith R Brain Commun. 2024; 6(6):fcae414.

PMID: 39605973 PMC: 11601160. DOI: 10.1093/braincomms/fcae414.

Single Intranasal Administration of Ucn3 Affects the Development of PTSD Symptoms in an Animal Model.

Tillinger A, Zvozilova A, Mach M, Horvathova L, Dziewiczova L, Osacka J Int J Mol Sci. 2024; 25(22).

PMID: 39595978 PMC: 11594197. DOI: 10.3390/ijms252211908.

Sex differences in contextual fear conditioning and extinction after acute and chronic nicotine treatment.

Keady J, Hessing M, Songrady J, McLaurin K, Turner J Biol Sex Differ. 2024; 15(1):88.

PMID: 39482781 PMC: 11529327. DOI: 10.1186/s13293-024-00656-6.

Post traumatic stress disorder associated hypothalamic-pituitary-adrenal axis dysregulation and physical illness.

Lawrence S, Scofield R Brain Behav Immun Health. 2024; 41:100849.

PMID: 39280087 PMC: 11401111. DOI: 10.1016/j.bbih.2024.100849.

Advances in the role of the GADD45 family in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders.

Huang M, Wang J, Liu W, Zhou H Front Neurosci. 2024; 18:1349409.

PMID: 38332860 PMC: 10850240. DOI: 10.3389/fnins.2024.1349409.

References

Jolkkonen J, Lepola U, Bissette G, Nemeroff C, RIEKKINEN P . CSF corticotropin-releasing factor is not affected in panic disorder. Biol Psychiatry. 1993; 33(2):136-8. DOI: 10.1016/0006-3223(93)90315-5. View

Yehuda R, Southwick S, Krystal J, Bremner D, Charney D, Mason J . Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry. 1993; 150(1):83-6. DOI: 10.1176/ajp.150.1.83. View

Kling M, Rubinow D, Doran A, Roy A, Davis C, Calabrese J . Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Neuroendocrinology. 1993; 57(1):79-88. DOI: 10.1159/000126345. View

Owens M, Nemeroff C . The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp. 1993; 172:296-308; discussion 308-16. DOI: 10.1002/9780470514368.ch15. View

Licinio J, Seibyl J, Altemus M, Charney D, Krystal J . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry. 1993; 150(9):1408-10. DOI: 10.1176/ajp.150.9.1408. View

Wallace J, Boichot E, Sidoti C, Brecx A . Protective effects of somatostatin against gastric damage induced by hemorrhagic shock, stress and PAF in the rat. Regul Pept. 1993; 47(2):195-203. DOI: 10.1016/0167-0115(93)90424-7. View

Benyassi A, Roussel J, Rougeot C, Gavalda A, ASTIER H, Arancibia S . Chronic stress affects in vivo hypothalamic somatostatin release but not in vitro GH responsiveness to somatostatin in rats. Neurosci Lett. 1993; 159(1-2):166-70. DOI: 10.1016/0304-3940(93)90825-6. View

Hawley R, Nemeroff C, Bissette G, Guidotti A, Rawlings R, Linnoila M . Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcohol Clin Exp Res. 1994; 18(6):1312-6. DOI: 10.1111/j.1530-0277.1994.tb01429.x. View

Bremner J, Randall P, Scott T, Bronen R, Seibyl J, Southwick S . MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995; 152(7):973-81. PMC: 3233767. DOI: 10.1176/ajp.152.7.973. View

10.

Sharma R, Bissette G, Janicak P, Davis J, Nemeroff C . Elevation of CSF somatostatin concentrations in mania. Am J Psychiatry. 1995; 152(12):1807-9. DOI: 10.1176/ajp.152.12.1807. View

11.

Coplan J, Andrews M, Rosenblum L, Owens M, Friedman S, Gorman J . Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci U S A. 1996; 93(4):1619-23. PMC: 39991. DOI: 10.1073/pnas.93.4.1619. View

12.

Fossey M, Lydiard R, Ballenger J, Laraia M, Bissette G, Nemeroff C . Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry. 1996; 39(8):703-7. DOI: 10.1016/0006-3223(95)00197-2. View

13.

Dallman M, Jones M . Corticosteroid feedback control of ACTH secretion: effect of stress-induced corticosterone ssecretion on subsequent stress responses in the rat. Endocrinology. 1973; 92(5):1367-75. DOI: 10.1210/endo-92-5-1367. View

14.

Feldman S, Conforti N . Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity. Neuroendocrinology. 1980; 30(1):52-5. DOI: 10.1159/000122974. View

15.

Brown M, Fisher L, Rivier J, Spiess J, Rivier C, Vale W . Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci. 1982; 30(2):207-10. DOI: 10.1016/0024-3205(82)90654-3. View

16.

Sutton R, Koob G, Le Moal M, Rivier J, Vale W . Corticotropin releasing factor produces behavioural activation in rats. Nature. 1982; 297(5864):331-3. DOI: 10.1038/297331a0. View

17.

Post R, Gold P, Rubinow D, Ballenger J, Bunney Jr W, Goodwin F . Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sci. 1982; 31(1):1-15. DOI: 10.1016/0024-3205(82)90394-0. View

18.

Britton D, Koob G, Rivier J, Vale W . Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 1982; 31(4):363-7. DOI: 10.1016/0024-3205(82)90416-7. View

19.

Valentino R, Foote S, Aston-Jones G . Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 1983; 270(2):363-7. DOI: 10.1016/0006-8993(83)90615-7. View

20.

Ehlers C, Henriksen S, Wang M, Rivier J, Vale W, Bloom F . Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res. 1983; 278(1-2):332-6. DOI: 10.1016/0006-8993(83)90266-4. View